Albert Reese - May 18, 2022 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Albert Reese Jr./
Stock symbol
LEXX
Transactions as of
May 18, 2022
Transactions value $
$6,431
Form type
4
Date filed
5/19/2022, 04:47 PM
Previous filing
Mar 8, 2022
Next filing
May 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX common shares Award $3.41K +1.7K +185.39% $2.01 2.62K May 18, 2022 Direct
transaction LEXX common shares Award $3.02K +1.5K +57.36% $2.01 4.12K May 19, 2022 Direct
holding LEXX common shares 917 May 18, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 3.4K May 18, 2022 Common Shares 3.4K $4.80 Direct
holding LEXX Stock Options 6.8K May 18, 2022 Common Shares 3.4K $3.39 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.